Statistics for Effect of Empagliflozin Beyond Glycemic Control: Cardiovascular Benefit in Patients with Type 2 Diabetes and Established Cardiovascular Disease
Total visits
| views | |
|---|---|
| Effect of Empagliflozin Beyond Glycemic Control: Cardiovascular Benefit in Patients with Type 2 Diabetes and Established Cardiovascular Disease | 57 |
Total visits per month
| views | |
|---|---|
| November 2024 | 4 |
| December 2024 | 0 |
| January 2025 | 0 |
| February 2025 | 0 |
| March 2025 | 0 |
| April 2025 | 0 |
| May 2025 | 0 |
File Visits
| views | |
|---|---|
| RPC 2019 721.pdf(legacy) | 47 |
| RPC 2019 721.pdf | 2 |
Top country views
| views | |
|---|---|
| United States | 32 |
| China | 12 |
| India | 4 |
| Australia | 2 |
| Sweden | 2 |
| Mongolia | 1 |
| New Zealand | 1 |
| Ukraine | 1 |